Toshiba America Medical Systems showcased two models of cardiac ultrasound systems, members of the company’s PowerVision family, at this year’s American College of Cardiology convention in March. The PowerVision 6000 was released two years ago
Toshiba America Medical Systems showcased two models of cardiac ultrasound systems, members of the companys PowerVision family, at this years American College of Cardiology convention in March.
The PowerVision 6000 was released two years ago and the PowerVision 8000 was released at the Radiological Society of North Americas annual meeting last year. A combination of hardware and software allows both systems to perform head-to-toe scanning using a number of applications, including contrast agents, harmonic tissue imaging, and digital imaging.
The difference between the two systems lies in the number of channels, said Scott Yarde, Toshibas ultrasound marketing manager. The 6000 model has 256 channels and the 8000 model has 512 channels.
In addition to plug-and-play transducers, the PowerVision 8000 contains an integrated digital information system package that Tustin, CA-based Toshiba has named PowerView. The PowerView package supports all DICOM service classes and stress echo software. Three-dimensional capabilities and live digital video streaming for telemedicine are being developed.
Clinicians can purchase the PowerView package as an option for the 6000 model. Both systems are capable of quantifying blood flow and perfusion, but these studies have yet to be widely used, Yarde said. The PowerVision 8000 is most appropriate for large, multidepartment hospitals, he said.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.